High-dose statin therapy linked to diabetes

Three recent trials comparing intensive- to moderate-dose statin therapy have suggested an increased risk of incident diabetes in patients treated with high-dose statin regimens.  To investigate this phenomenon further, the authors conducted a collaborative meta-anlysis of published and unpublished data from five statin trials, all of which were randomise controlled end-point trials that compared intensive-dose […]

Read More…

Lipid metabolism by gut flora influences cardiovascular disease

Although the relationship between cholesterol, triglycerides, and cardiovascular disease is well established, little is known about the role of the third major class of lipids – phospholipids.  In this regard, the intestinal microflora play a crucial role in that they digest and absorb many crucial nutrients, including lipids.  Therefore in this study the authors attempted […]

Read More…

LDL cholesterol lowering in CKD looks SHARP

While the cardiovascular benefits of LDL cholesterol lowering in patients without kidney disease are well established, the effects on people with moderate to severe kidney disease has remained unproven. The SHARP (Study of Heart and Renal Protection) study was a randomised double-blind trial that included 9270 patients with chronic kidney disease (3023 of whom were […]

Read More…

STICH examines the role of CABG in heart failure

While the efficacy of CABG in improving both morbidity and mortality in patients with severe coronary artery disease and angina was established in the 1970’s, the majority of patients who took part in these initial ground-breaking studies had normal or near normal ventricular function.  The role of CABG in treating patients with poor systolic LV […]

Read More…

PRECOMBAT: PCI viable for unprotected left main disease

The SYNTAX study, which randomised patients with complex severe coronary disease to either CABG or PCI, found that CABG remains a superior treatment option for the majority of these patients.  However, in a substudy of patients who had left main stem (LMS) disease, SYNTAX suggested equipoise between the two treatments.  Since then, the debate about […]

Read More…

Coronary CT in a low-risk population

The role of atherosclerotic plaque imaging techniques in the primary prevention of cardiovascular disease remains to be determined.  Perhaps the most promising technique at the moment is coronary CT, which has a high sensitivity for the detection of atherosclerosis.  However, the benefits of CT must be balanced against the risks of contrast and radiation exposure. […]

Read More…

Medical therapy underused in patients undergoing PCI

Optimal medical therapy (OMT) has previously been shown to lead to similar rates of cardiovascular events as percutaneous coronary intervention (PCI) in patients with stable coronary artery disease.  Most noticeably, the COURAGE trial showed that PCI did not improve patient survival or prevent myocardial infarction.  However, it is also known that the findings of important […]

Read More…

CABG rates decline in USA over the last decade

Coronary revascularisation, either by coronary artery bypass surgery (CABG) or percutaneous coronary intervention (PCI), is one of the most commonly performed procedures in the USA.  Over the last ten years a number of technological and pharmacological improvements have changed the landscape of coronary revascularisation and led to a number of changes in guidelines and appropriateness […]

Read More…